z-logo
Premium
Chagas’ disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test
Author(s) -
Gadelha A. Á. M.,
Verçosa A. F. A.,
Lorena V. M. B.,
Nakazawa M.,
Carvalho A. B.,
Souza W. V.,
Ferreira A. G. P.,
Silva E. D.,
Krieger M. A.,
Goldenberg S.,
Gomes Y. M.
Publication year - 2003
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1046/j.1423-0410.2003.00340.x
Subject(s) - chagas disease , serology , recombinant dna , hemagglutination , medicine , virology , antibody , antigen , immunology , biology , biochemistry , gene
Background and Objectives  Serological screening for Chagas’ disease in the blood banks of South America is carried out by using two different assays that generally show a high number of inconclusive results. To establish a combination of two tests that can minimize the number of inconclusive results, we compared a recombinant enzyme‐linked immunosorbent assay (ELISA) with two conventional tests. Materials and Methods  Serum samples from chagasic patients ( n  = 112), from non‐chagasic individuals ( n  = 143) and from patients with other diseases ( n  = 32) were tested using three assays: recombinant ELISA (Rec‐ELISA); conventional ELISA (Con‐ELISA); and the indirect haemagglutination (IHA) test. Results  When we evaluated the data by matching the Rec‐ELISA and the IHA test, 52 inconclusive results were obtained. When Rec‐ELISA and Con‐ELISA were matched, only four inconclusive results were observed. Conclusions  Our investigation indicates that the use of two ELISAs with different antigen preparations provides an effective test combination for blood bank screening of Chagas’ disease.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here